Revance Therapeutics Inc. (RVNC)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

3.08

-0.16%

After-hours Dec 13, 2024, 07:58 PM EST

Revance Therapeutics Inc. Forcast

Stock Price Forecast

The 9 analysts with 12-month price forecasts for RVNC stock have an median target of 6.8, with a low estimate of 6 and a high estimate of 8. The median target predicts an increase of 120.78% from the current stock price of 3.08.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$6	$6.9	$6.8	$8
Change	94.81%	124.03%	120.78%	159.74%

AI Analyst Report

HC Wainwright & Co. maintains a Neutral rating on ... Unlock content with Pro Subscription

Updated Nov 08, 2024

Rating	May 24	Aug 24	Sep 24	Oct 24	Nov 24	Dec 24
Strong Buy	0	0	0	0	0	0
Buy	3	3	0	0	0	0
Hold	2	3	1	1	2	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	6	1	1	2	1

Financial Forecast this Year

Revenue This Year

275.67M

from 234.04M

17.8%

from 234.04M

Revenue Next Year

362.03M

from 275.67M

31.3%

from 275.67M

EPS This Year

-1.03

from -3.83

73.1%

from -3.83

EPS Next Year

-0.7

from -1.03

32.0%

from -1.03